Literature DB >> 17464917

Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

Arnaldo L Colombo1, Thaís Guimarães, Ligia R B F Silva, Leila Paula de Almeida Monfardini, Anna Karenine B Cunha, Patrícia Rady, Thelma Alves, Robert C Rosas.   

Abstract

BACKGROUND: Studies conducted in tertiary care hospitals of different European countries and the United States have shown incidence rates of candidemia ranging from 0.17 to 0.76 and 0.28 to 0.96 per 1,000 admissions, respectively. So far, only 1 study has evaluated the incidence rates of candidemia in tertiary care hospitals in Latin American countries.
OBJECTIVE: To evaluate the epidemiology of candidemia in 4 tertiary care hospitals in São Paulo, Brazil.
DESIGN: Multicenter, laboratory-based surveillance of candidemia.
RESULTS: A total of 7,038 episodes of bloodstream infection were identified, and Candida species accounted for 282 cases (4%). The incidence rate of candidemia was 1.66 candidemic episodes per 1,000 hospital admissions. Candida albicans was the most frequently isolated Candida species in all hospitals, but Candida species other than C. albicans accounted for 62% of isolates, including predominantly Candida parapsilosis and Candida tropicalis. Azole resistance was restricted to only 2% of all Candida isolates (1 isolate of Candida glabrata and 4 isolates of Candida rugosa). Candidemia was mostly documented in surgical patients with long durations of hospital stay. The crude mortality rate was 61%, and advanced age and high Acute Physiology and Chronic Health Evaluation II score were both conditions independently associated with risk of death.
CONCLUSIONS: We observed in our series a higher incidence rate of candidemia than that reported in European countries and the United States. Advanced age and a high Acute Physiology and Chronic Health Evaluation II score were factors associated with a higher probability of death in candidemic patients. Fluconazole-resistant Candida strains are still a rare finding in our case-based study of candidemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464917     DOI: 10.1086/513615

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  49 in total

1.  Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Authors:  Hugo Dias Hoffmann-Santos; Claudete Rodrigues Paula; Ana Caroline Akeme Yamamoto; Tomoko Tadano; Rosane C Hahn
Journal:  Mycopathologia       Date:  2013-10-11       Impact factor: 2.574

2.  Phenotypic switching of Candida tropicalis is associated with cell damage in epithelial cells and virulence in Galleria mellonella model.

Authors:  Alane T-P Moralez; Hugo F Perini; Luciana Furlaneto-Maia; Ricardo S Almeida; Luciano A Panagio; Marcia C Furlaneto
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

3.  Repeated applications of photodynamic therapy on Candida glabrata biofilms formed in acrylic resin polymerized.

Authors:  Lírian Silva de Figueiredo Freitas; Rodnei Dennis Rossoni; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  Lasers Med Sci       Date:  2017-01-14       Impact factor: 3.161

4.  Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Authors:  S J Taj-Aldeen; A Kolecka; R Boesten; A Alolaqi; M Almaslamani; P Chandra; J F Meis; T Boekhout
Journal:  Infection       Date:  2013-12-19       Impact factor: 3.553

Review 5.  Insights into Candida tropicalis nosocomial infections and virulence factors.

Authors:  M Negri; S Silva; M Henriques; R Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-30       Impact factor: 3.267

6.  Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials.

Authors:  D L Horn; L Ostrosky-Zeichner; M I Morris; A J Ullmann; C Wu; D N Buell; L L Kovanda; O A Cornely
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-15       Impact factor: 3.267

Review 7.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.

Authors:  Arianna Tavanti; Lambert A M Hensgens; Selene Mogavero; László Majoros; Sonia Senesi; Mario Campa
Journal:  BMC Microbiol       Date:  2010-07-28       Impact factor: 3.605

9.  DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses.

Authors:  Daniele Campa; Arianna Tavanti; Federica Gemignani; Crocifissa S Mogavero; Ilaria Bellini; Fabio Bottari; Roberto Barale; Stefano Landi; Sonia Senesi
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

10.  Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.

Authors:  Bertrand F Dupont; Olivier Lortholary; Luis Ostrosky-Zeichner; Flavie Stucker; Vijay Yeldandi
Journal:  Crit Care       Date:  2009-10-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.